{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T05:26:56Z","timestamp":1730870816693,"version":"3.28.0"},"reference-count":30,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An\u00e4sthesiol Intensivmed Notfallmed Schmerzther"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1055\/a-2250-8816","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T23:30:26Z","timestamp":1707953426000},"page":"114-121","source":"Crossref","is-referenced-by-count":0,"title":["Konservative Therapie und Sekund\u00e4rpr\u00e4vention der pAVK"],"prefix":"10.1055","volume":"59","author":[{"given":"Katja S.","family":"M\u00fchlberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,2,14]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"100113","DOI":"10.1016\/j.lanepe.2021.100113","article-title":"Peripheral artery disease in Germany (2009\u20132018): Prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy \u2013 A populationbased study","volume":"5","author":"C Rammos","year":"2021","journal-title":"Lancet Reg Health Eur"},{"issue":"S 02","key":"ref2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00059-020-04998-w","article-title":"Medikament\u00f6se Sekund\u00e4rpr\u00e4vention bei Patienten mit peripherer arterieller Verschlusskrankheit: Eine sekund\u00e4rdatenbasierte Analyse [Medication-based secondary prevention in patients with\n          peripheral arterial occlusive disease: An analysis based on secondary data]","volume":"46","author":"K Gebauer","year":"2021","journal-title":"Herz"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s40265-022-01756-6","article-title":"Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis","volume":"82","author":"LH Willems","year":"2022","journal-title":"Drugs"},{"issue":"39","key":"ref4","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1093\/eurheartj\/ehab390","article-title":"Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working\n          group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy","volume":"42","author":"V Aboyans","year":"2021","journal-title":"Eur Heart J"},{"issue":"06","key":"ref5","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1177\/17085381211043952","article-title":"Effects of lipid-lowering therapy on major adverse limb events in patients with peripheral arterial disease: A meta-analysis of randomized clinical trials","volume":"30","author":"W Masson","year":"2022","journal-title":"Vascular"},{"issue":"09","key":"ref6","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"ESC Scientific Document Group. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS):\n          Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The\n          Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)","volume":"39","author":"V Aboyans","year":"2018","journal-title":"Eur Heart J"},{"issue":"15","key":"ref7","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"CLEAR Outcomes Investigators. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients","volume":"388","author":"SE Nissen","year":"2023","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0140-6736(22)00916-3","article-title":"RACING investigators. Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with\n          atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial","volume":"400","author":"BK Kim","year":"2022","journal-title":"Lancet"},{"issue":"S 102","key":"ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1024\/0301-1526\/a000834","article-title":"ESVM Guideline on peripheral arterial disease","volume":"48","author":"U Frank","year":"2019","journal-title":"Vasa"},{"issue":"04","key":"ref10","first-page":"117","article-title":"Auswahl von Statinen vor dem Hintergrund neu verfasster Lipidleitlinien","volume":"38","author":"HP Lipp","year":"2020","journal-title":"Arzneimitteltherapie"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1055\/a-1516-2471","article-title":"State of the Art: Therapie mit Statinen [State of the Art: Statin Therapy]","volume":"147","author":"U Laufs","year":"2022","journal-title":"Dtsch Med Wochenschr"},{"issue":"14","key":"ref12","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.3390\/jcm10143071","article-title":"Cardiac Rehabilitation in German Speaking Countries of Europe-Evidence-Based Guidelines from Germany, Austria and Switzerland LLKardReha-DACH-Part 2","volume":"10","author":"B Schwaab","year":"2021","journal-title":"J Clin Med"},{"issue":"06","key":"ref13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1055\/a-2071-8900","article-title":"Smoking cessation in hospitalised patients \u2013 Initiate among inpatients, continue when outpatients \u2013 A Position Paper by the German Respiratory Society (DGP) Taskforce for Smoking\n          Cessation","volume":"7","author":"M Raspe","year":"2023","journal-title":"Pneumologie"},{"issue":"05","key":"ref15","doi-asserted-by":"publisher","first-page":"CD006103","DOI":"10.1002\/14651858.CD006103.pub8","article-title":"Nicotine receptor partial agonists for smoking cessation","volume":"5","author":"J Livingstone-Banks","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"02","key":"ref16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1024\/0301-1526\/a001056","article-title":"DGA-German Society of Angiology Board; ESVM-European Society of Vascular Medicine Board. Health effects of e-cigarettes and their use for smoking cessation from a vascular perspective","volume":"52","author":"B Krabbe","year":"2023","journal-title":"Vasa"},{"issue":"03","key":"ref17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/FJC.0000000000001195","article-title":"Efficacy and Safety of Cilostazol for Atherosclerosis: A Meta-analysis of Randomized Controlled Trials","volume":"79","author":"H Wan","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"issue":"02","key":"ref18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.jvs.2020.08.125","article-title":"Literature review and meta-analysis of the efficacy of cilostazol on limb salvage rates after infrainguinal endovascular and open revascularization","volume":"73","author":"K Desai","year":"2021","journal-title":"J Vasc Surg"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.3390\/jcm10215033","article-title":"Diabetes Mellitus and its impact on patientprofile and in-hospital outcomes in peripheral artery disease","volume":"10","author":"K Keller","year":"2021","journal-title":"J Clin Med"},{"issue":"18","key":"ref20","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1093\/eurheartj\/ehaa956","article-title":"The association of amputations and peripheral artery disease in patients with type 2 diabetes mellitus receiving sodium-glucose cotransporter type-2 inhibitors: real-world study","volume":"42","author":"SK Paul","year":"2021","journal-title":"Eur Heart J"},{"issue":"01","key":"ref21","doi-asserted-by":"publisher","first-page":"e2252239","DOI":"10.1001\/jamanetworkopen.2022.52239","article-title":"Adherence to a Healthy Lifestyle in Association With Microvascular Complications Among Adults With Type 2 Diabetes","volume":"6","author":"G Liu","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"06","key":"ref22","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1161\/ATVBAHA.120.315482","article-title":"Million Veteran Program. Association Between Genetic Variation in Blood Pressure and Increased Lifetime Risk of Peripheral Artery Disease","volume":"41","author":"MG Levin","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"18","key":"ref23","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1177\/2047487319846999","article-title":"Follow-up of patients after revascularisation for peripheral arterial diseases: a consensus document from the European Society of Cardiology Working Group on Aorta and Peripheral Vascular\n          Diseases and the European Society for Vascular Surgery","volume":"26","author":"M Venermo","year":"2019","journal-title":"Eur J Prev Cardiol"},{"issue":"12","key":"ref24","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.jacc.2023.01.025","article-title":"Integrating Psychosocial Care in the Management of Patients With Vascular Disease","volume":"81","author":"KG Smolderen","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jacc.2019.03.013","article-title":"Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES Trial","volume":"74","author":"JW Jukema","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"02","key":"ref26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S2213-8587(22)00353-9","article-title":"Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1\n          trial","volume":"11","author":"KK Ray","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"22","key":"ref27","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1056\/NEJMc2031173","article-title":"N-of-1 trial of a statin, placebo, or no treatment to assess side effects","volume":"383","author":"FA Wood","year":"2020","journal-title":"N Eng J of Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"n135","DOI":"10.1136\/bmj.n135","article-title":"Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials","volume":"372","author":"E Herrett","year":"2021","journal-title":"BMJ"},{"issue":"34","key":"ref29","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/eurheartj\/ehac015","article-title":"Prevalence of statin intolerance: a meta-analysis","volume":"43","author":"I Byty\u00e7i","year":"2022","journal-title":"Eur Heart J"},{"issue":"02","key":"ref30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/dom.13891","article-title":"Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes","volume":"22","author":"J Ghouse","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and Cardiovascular and Renal Events in type 2 Diabetes","volume":"377","author":"B Neal","year":"2017","journal-title":"N Engl J Med"}],"container-title":["AINS - An\u00e4sthesiologie \u00b7 Intensivmedizin \u00b7 Notfallmedizin \u00b7 Schmerztherapie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2250-8816.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T12:44:42Z","timestamp":1730810682000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2250-8816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":30,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2024,2,14]]},"published-print":{"date-parts":[[2024,2]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2250-8816","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0939-2661","1439-1074"],"issn-type":[{"type":"print","value":"0939-2661"},{"type":"electronic","value":"1439-1074"}],"subject":[],"published":{"date-parts":[[2024,2]]}}}